Jacobson Pharma Announces FY2023 Interim Results
HONG KONG, Nov 25, 2022 – (ACN Newswire via SEAPRWire.com) – Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Company”; Stock Code: 2633), a leading company engaged in the research, […]
Ban Loong, Jacobson & JBM Form Joint Venture to Tap Specialty Drugs and Branded Healthcare Markets in Greater China and Asia
HONG KONG, Jun 15, 2022 – (ACN Newswire via SEAPRWire.com) – Ban Loong Holdings Limited (“Ban Loong”, together with its subsidiaries, “Ban Loong Group”; stock code: 0030.HK), of which Yunnan […]
Jacobson Pharma’s Proposed Spin-off and Separate Listing of JBM (Healthcare) Limited on The Main Board of The Stock Exchange of Hong Kong Limited
HONG KONG, Jan 15, 2021 – (ACN Newswire) – Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Company”; Stock Code: 2633), a leading company engaged in the research, development, production, […]
Jacobson Pharma Announces FY2021 Interim Results
HONG KONG, Nov 27, 2020 – (ACN Newswire) – Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Company”; Stock Code: 2633), a leading company engaged in the research, development, production, […]